Angion Biomedica Corp. | Business Contracts

Angion Biomedica Corp. Retention Bonus Plan (Filed With SEC on February 13, 2023)

Form of Lock-Up Agreement, dated January 17, 2023 (Filed With SEC on January 17, 2023)

Note Purchase Agreement, dated January 17, 2023, by and between Elicio Therapeutics, Inc. and Angion Biomedica Corp., and Form of Promissory Note (Filed With SEC on January 17, 2023)

Agreement and Plan of Merger and Reorganization, dated January 17, 2023, by and among Angion Biomedica Corp., Arkham Merger Sub, Inc. and Elicio Therapeutics, Inc (Filed With SEC on January 17, 2023)

Supply Agreement, dated December 10, 2022, by and between Angion Biomedica Corp. and Solara Active Pharma Sciences, Ltd (Filed With SEC on March 30, 2022)

Agreement of Lease, dated June 21, 2011, by and between Angion Biomedica Corp. and NovaPark LLC, as amended (Filed With SEC on January 15, 2021)

Form of Elicio Therapeutics, Inc. Stockholder Support Agreement, dated January 17, 2023 (Filed With SEC on January 17, 2023)

Form of Angion Biomedica Corp. Stockholder Support Agreement, dated January 17, 2023 (Filed With SEC on January 17, 2023)

First Amendment dated September 9, 2022 to Consulting Agreement, dated June 3, 2020, as amended, by and between Angion Biomedica Corp. and Gregory S. Curhan (Filed With SEC on March 30, 2022)

Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 30, 2022)

Amendment First Amendment dated July 1, 2021 to Licensing Agreement, dated November 6, 2020, by and between Angion Biomedica Corp. and Vifor (International) Ltd (Filed With SEC on March 30, 2022)

Separation Agreement, dated February 25, 2022, by and between Angion Biomedica Corp. and Itzhak D. Goldberg (Filed With SEC on March 30, 2022)

Separation Agreement, dated March 1, 2022, by and between Angion Biomedica Corp. and Elisha Goldberg (Filed With SEC on March 30, 2022)

Second Amendment dated December 1, 2021 to Consulting Agreement, dated June 3, 2020, as amended, by and between Angion Biomedica Corp. and Gregory S. Curhan (Filed With SEC on March 30, 2022)

Third Amendment dated March 17, 2022 to Consulting Agreement, dated June 3, 2020, as amended, by and between Angion Biomedica Corp. and Gregory S. Curhan (Filed With SEC on March 30, 2022)

Non-Employee Director Compensation Program (Filed With SEC on March 30, 2022)

Amended and Restated Executive Separation Benefits Plan dated November 19, 2021 (Filed With SEC on March 30, 2022)

Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 30, 2021)

Stock Purchase Agreement, dated February 4, 2021, by and among Angion Biomedica Corp. and the purchasers named therein (Filed With SEC on February 9, 2021)

Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under the 2021 Incentive Award Plan (Filed With SEC on February 1, 2021)

ANGION BIOMEDICA CORP. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM (Filed With SEC on February 1, 2021)

2021 Employee Stock Purchase Plan (Filed With SEC on February 1, 2021)

Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2021 Incentive Award Plan (Filed With SEC on February 1, 2021)

Form of Stock Option Grant Notice and Stock Option Agreement under the 2021 Incentive Award Plan (Filed With SEC on February 1, 2021)

Form of Common Stock Certificate (Filed With SEC on February 1, 2021)

Form of Underwriting Agreement (Filed With SEC on February 1, 2021)

2021 Incentive Award Plan (Filed With SEC on February 1, 2021)

Form of Convertible Promissory Note (Filed With SEC on January 15, 2021)

Form of Incentive Stock Option Grant under 2015 Equity Incentive Plan (Filed With SEC on January 15, 2021)

Form of Broker Warrant to Purchase Common Stock (Filed With SEC on January 15, 2021)

Registration Rights Agreement, dated as of March 31, 2020, by and among Angion Biomedica Corp. and the investors party thereto (Filed With SEC on January 15, 2021)

Licensing Agreement, dated August 22, 2018, by and between Angion Biomedica Corp. and Sinovant Sciences HK Limited (Filed With SEC on January 15, 2021)

Subcontractor Agreement, dated November 15, 2019, by and between Angion Biomedica Corp. and The Regents of the University of Michigan (Filed With SEC on January 15, 2021)

Licensing Agreement, dated November 6, 2020, by and between Angion Biomedica Corp. and Vifor (International) Ltd (Filed With SEC on January 15, 2021)

Second Amended and Restated 2015 Equity Incentive Plan (Filed With SEC on January 15, 2021)

Amended and Restated Employment Agreement, dated March 29, 2019, by and between Angion Biomedica Corp. and Jay R. Venkatesan (Filed With SEC on January 15, 2021)

Form of Non-Qualified Stock Option Grant under 2015 Equity Incentive Plan (Filed With SEC on January 15, 2021)

Form of Stock Option Exercise under 2015 Equity Incentive Plan (Filed With SEC on January 15, 2021)

Executive Employment Agreement, dated May 1, 2018, by and between Angion Biomedica Corp. and Itzhak D. Goldberg (Filed With SEC on January 15, 2021)

Executive Employment Agreement, dated December 17, 2018, by and between Angion Biomedica Corp. and John F. Neylan (Filed With SEC on January 15, 2021)

Offer Letter, dated November 27, 2019, as amended, by and between Angion Biomedica Corp. and Jennifer J. Rhodes (Filed With SEC on January 15, 2021)

Consulting Agreement, dated June 3, 2020, as amended, by and between Angion Biomedica Corp. and Greg Curhan (Filed With SEC on January 15, 2021)

Non-Employee Director Compensation Program (Filed With SEC on January 15, 2021)

Form of Indemnification Agreement for directors and officers (Filed With SEC on January 15, 2021)

Promissory Note and Agreement, dated April 21, 2020, by and between Angion Biomedica Corp. and Hanmi Bank (Filed With SEC on January 15, 2021)

Form of Warrant to Purchase Common Stock (Filed With SEC on January 15, 2021)

Angion Biomedica Corp. (46)